Ge Long Hui A P P
Search documents
德银:软件、科技板块对投机级信贷市场构成重大集中风险
Ge Long Hui A P P· 2026-02-10 07:21
格隆汇2月10日|德银分析师指出,软件及科技行业对投机级信贷市场构成历来最重大的集中风险之 一。软件及科技行业在投机级信贷市场中的规模分别达5970亿美元及6810亿美元,占整体比重约14%及 16%。投机级债务涵盖高收益债券、杠杆贷款及美国私募信贷。分析师指出,相关规模属相当可观的未 偿还债务,一旦软件行业违约情况上升,或会拖累整体市场情绪,其潜在影响可与2016年能源行业危机 相提并论。 ...
A股异动︱欣灵电气跌逾4% 股东张彭春拟减持不超1.28%公司股份
Ge Long Hui A P P· 2026-02-10 07:12
欣灵电气(301388.SZ)今日盘中一度跌4.5%至34.38元。欣灵电气公布,董事兼总经理张彭春先生计划自本公告披露之日起十五个交易日后的3个月内以集中竞 价方式或大宗交易方式减持本公司股份不超过1.28%。(格隆汇) ...
研报掘金丨国盛证券:首予汇嘉时代“买入”评级,创新转型价值重估
Ge Long Hui A P P· 2026-02-10 06:53
国盛证券研报指出,汇嘉时代是新疆零售龙头,创新转型价值重估。公司的核心竞争优势在于其密集的 门店网络、深入的本土市场洞察以及多业态协同效应。这些优势使其在新疆地区形成了显著的规模效应 和品牌壁垒。公司积极推动超市调改和购物中心业态升级,创新性地探索"低空经济+消费"新场景,有 望打开第二增长曲线。首次覆盖给予"买入"评级。 ...
研报掘金丨东吴证券:维持欣旺达“买入”评级,目标价41元
Ge Long Hui A P P· 2026-02-10 06:44
东吴证券研报指出,欣旺达与威睿诉讼和解,港股上市推进顺利,动储业务高增长。测算25年欣旺达动 力计提费用12.5-20亿元,相关计提处理非常充分,不会影响26年及之后业绩,本次和解避免陷入长期 的价格战和诉讼战,同时消除对未来港股上市、海外扩张、新客户导入和银行合作等多方面的不确定 性,集中全部精力回归经营基本面。公司26年动力毛利率目标15%,同增2pct,储能目标10-12%,同增 2-3pct,海外客户占比提升(由30%提升至40-50%),并通过技术创新、规模效应、良率提升覆盖未传 导的成本,全年动力扭亏目标不变。由于诉讼事件影响25年盈利、但26、27年公司动储业务出货强劲, 预计25-27年归母净利润14.1/30.3/41.2亿元(原预测值为20.5/30.0/41.1亿元),同比-4%/+115%/+36%, 对应PE为32x/15x/11x,给予26年25x估值,对应目标价41元,维持"买入"评级。 ...
海螺新材(000619.SZ):未与马斯克团队接触,公司产品未应用于航空航天领域
Ge Long Hui A P P· 2026-02-10 06:42
Core Viewpoint - The company, Conch New Materials (000619.SZ), primarily engages in the research, production, and sales of plastic profiles, aluminum profiles, doors and windows, SCR denitration catalysts, and high molecular rollers. The company has not had any contact with Elon Musk's team, and its products are not utilized in the aerospace sector [1] Group 1 - The company specializes in various products including plastic profiles and aluminum profiles [1] - The company has confirmed no engagement with Elon Musk's team [1] - The company's products are not applied in the aerospace industry [1]
双乐股份(301036.SZ):公司的酞菁蓝15:6已量产,目前可以应用于高档油墨、高档涂料等领域
Ge Long Hui A P P· 2026-02-10 06:40
Core Viewpoint - Shuangle Co., Ltd. has successfully achieved mass production of Phthalocyanine Blue 15:6, which can be applied in high-end inks and coatings, with ongoing research for its use in display panels [1] Group 1 - The company has confirmed that Phthalocyanine Blue 15:6 is now in mass production [1] - Applications for the new product include high-end inks and high-end coatings [1] - Research and development for the application of Phthalocyanine Blue 15:6 in display panels is currently underway [1] Group 2 - The company has made adjustments to its high-performance production line for pigment purple, which can be utilized in the research and production of Phthalocyanine Blue 15:6 [1] - The production quantity of Phthalocyanine Blue 15:6 will depend on market demand [1]
创新药重磅BD频出,港股通创新药ETF、港股创新药ETF、恒生生物科技ETF、港股通医疗ETF上涨
Ge Long Hui A P P· 2026-02-10 06:37
港股通创新药ETF跟踪中证港股通创新药指数,指数编制方式更科学合理,成分股涵盖如百济神州、信达生物和药明生物等龙头企业。 港股通创新药ETF易方达是目前市场上唯一跟踪恒生港股通创新药指数的产品,该指数在编制方案中明确剔除了CXO公司,聚焦创新药产业核心企业,权重 股包括百济神州、信达生物、药明生物、康方生物等龙头公司,为投资者布局港股前沿创新药企提供了便捷工具。 港股创新药上涨,石药集团、药明生物、信达生物涨超5%,带动港股通创新药ETF嘉实、港股通创新药ETF万家、港股创新药50ETF、港股通创新药ETF鹏 华、港股创新药ETF、恒生生物科技ETF南方、港股通创新药ETF、港股创新药ETF、港股通创新药ETF南方、港股通创新药ETF工银、港股通创新药ETF、 恒生生物科技ETF易方达、 港股通医疗ETF富国上涨。 | 证券代码 | 证券简称 | 当日涨幅% | 年内涨幅 | 管理 | | --- | --- | --- | --- | --- | | 520970.SH | 港股通创新药ETF嘉实 | 3.27% | 11.03% | 嘉委 | | 520700.SH | 港股通创新药ETF万家 | 3.1 ...
通用汽车挖角Lucid高管,任命为副首席财务官兼战略主管
Ge Long Hui A P P· 2026-02-10 06:35
Core Insights - General Motors has appointed Claudia Gast as the new Vice President of Finance, Strategy, Corporate Development, and Technology Partnerships [1] - Gast previously held the position of Senior Vice President of Strategy and Business Development at electric vehicle startup Lucid Motors [1] - The automotive industry is increasingly hiring executives from electric vehicle startups and technology companies to navigate significant technological transformations, including electrification, autonomous driving, and software-centric vehicles [1]
研报掘金丨中邮证券:首予联动科技“买入”评级,大算力SoC测试机加速推进
Ge Long Hui A P P· 2026-02-10 06:31
中邮证券研报指出,联动科技营收稳健增长,股份支付短期影响业绩表现。得益于公司积极开拓市场, 产品销售收入有所增加。前三季度共计产生0.12亿元股份支付费用,股权激励股份支付分摊一定程度影 响了公司的利润水平。公司产品关键技术指标达国内领先、国际先进水平,核心竞争力突出;集成电路 测试系统兼具模拟与数字信号测试能力,核心性能指标与同类进口设备相当,具备较强的国产化替代潜 力。市场开拓多点发力,业务规模有序扩容,进一步夯实核心竞争壁垒。公司全力推进大规模数字SoC 类集成电路测试领域新产品的研发与验证工作,因产品技术复杂度高,验证周期相对较长。首次覆盖给 予"买入"评级。 ...
研报掘金丨东兴证券:维持兴森科技“推荐”评级,AI驱动IC载板涨价潮持续
Ge Long Hui A P P· 2026-02-10 06:31
Group 1 - The core viewpoint of the report indicates that the profitability of Xing Sen Technology's main business has significantly improved, with expectations to turn profitable by 2025 [1] - The AI-driven substrate market is experiencing high demand, and the company's scarce production capacity is becoming increasingly valuable [1] - Xing Sen Technology is one of the few domestic manufacturers with both BT and ABF substrate capabilities, making its production and technical capabilities particularly rare in the current market context [1] Group 2 - The demand for IC substrates is expected to continue rising due to explosive growth in AI chips, high-performance computing (HPC), and 5G communication sectors, leading the industry into a new growth phase [1] - The global IC substrate market is projected to reach USD 16.69 billion by 2025, increase to USD 18.44 billion by 2026, and eventually expand to USD 45.34 billion by 2035 [1] - The market is anticipated to grow at a robust compound annual growth rate (CAGR) of 10.51% from 2026 to 2035 [1] Group 3 - The company is expected to benefit from the AI wave, with its PCB and semiconductor businesses continuing to perform well [1] - Earnings per share (EPS) projections for the company are estimated at CNY 0.08, CNY 0.25, and CNY 0.40 for the years 2025, 2026, and 2027 respectively [1] - The report maintains a "recommend" rating for the company [1]